Teriparatide Injection, Solution
Product Images NDC 47781-652

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Teriparatide (NDC 47781-652). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alvogen, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

This is a description of Teriparatide Injection, which contains 250 mcg teriparatide, 0.41 mg glacial acetic acid, 0.10 mg sodium acetate, 45.4 mg mannitol, 3 mg metacresol, and water for injection. The recommended dosage is 20 mcg teriparatide once a day. The injection should be kept in the refrigerator, and it should not be frozen. The medication is for subcutaneous use only. The user is advised to read the User Manual before injecting and to discard the unused portion 28 days after first use. The prescription information and device User Manual are provided in the carton.*

FDA Label Image

Figure-1 (Figure 1)

This is information on a clinical trial involving teriparatide and a placebo. The rest of the text contains errors and is not readable.*

FDA Label Image

Ifu-fig-a (Ifu Fig A)

Teriparatide Injection is a medical device that requires needles, not included with the product. It is recommended to use Becton, Dickinson and Company pen needles with gauges from 29 to 31. The device has a white outer needle cover, an inner needle cover, a paper tab, a teal body, an instruction window, and a black injection button, as shown in Figure A.*

FDA Label Image

Ifu-fig-b (Ifu Fig B)

FDA Label Image

Ifu-fig-c (Ifu Fig C)

FDA Label Image

Ifu-fig-d (Ifu Fig D)

FDA Label Image

Ifu-fig-e-f (Ifu Fig E F)

FDA Label Image

Ifu-fig-g (Ifu Fig G)

FDA Label Image

Ifu-fig-h (Ifu Fig H)

FDA Label Image

Ifu-fig-i (Ifu Fig I)

The text provided is not available, as it consists of only a few product names and a partial figure reference.*

FDA Label Image

Ifu-fig-j (Ifu Fig J)

FDA Label Image

Ifu-fig-k (Ifu Fig K)

FDA Label Image

Ifu-fig-l (Ifu Fig L)

FDA Label Image

Ifu-fig-m (Ifu Fig M)

FDA Label Image

Ifu-fig-n (Ifu Fig N)

FDA Label Image

Ifu-fig-o (Ifu Fig O)

FDA Label Image

Ifu-fig-p-q (Ifu Fig P Q)

FDA Label Image

Ifu-fig-r (Ifu Fig R)

FDA Label Image

Ifu-fig-s (Ifu Fig S)

FDA Label Image

Ifu-fig-t (Ifu Fig T)

FDA Label Image

Ifu-fig-u (Ifu Fig U)

FDA Label Image

Ifu-fig-v (Ifu Fig V)

FDA Label Image

Ifu-important-info (Ifu Important Info)

FDA Label Image

Ifu-ts-problem-a (Ifu Ts Problem A)

FDA Label Image

Pen-label (Pen Label)

This is a description of Teriparatide Injection, a prescription-only medication contained in a single-patient-use pen. The medication contains 620 mcg/2.48 mL (250 mcg/mL) and should be administered subcutaneously in 20 mcg doses. The User Manual should be read before use, and the medication should not be transferred to a syringe. Each pen can deliver 28 doses and should be thrown away after 28 days of use. The medication should be refrigerated and not frozen. It is distributed by Alvogen, Inc. in Morristown, NJ, USA.*

FDA Label Image

Amino-acid-sequence (Teriparatide)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.